Just-in-Time Practices to Prevent Weight Regain from Stopping Your Progress
Official title: Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
Run by ORI Community and Evaluation Services · NCT07708064 · Data updated 2026-11-12
This trial tests whether sending brief mindfulness and self-compassion exercises right after weight regain or a missed weigh-in helps people stick with their long-term weight goals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | ORI Community and Evaluation Services Academic / other |
| Locations | 1 site (Springfield, Oregon) |
| Status | Recruiting |
| Started | July 14, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07708064 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-75 with BMI 25-50 kg/m2 who recently weighed at least 3% less than their highest weight in the past 3 years and want to maintain or further lose weight.
✕Probably not a fit
Individuals who do not experience weight regain or who cannot engage with a smartphone app may see little benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with overweight or obesity who have recently maintained a loss are randomized to receive either immediate short exercises via a smartphone app after weight regain or missed weigh-ins, or weekly reminders of standard weight-control strategies. The intervention uses mindfulness, acceptance, and self-compassion techniques to sustain motivation. The study aims to see if this timely, adaptive support improves weight maintenance compared to routine reminders.
Why it matters
Potential benefit: If successful, the approach could help people maintain weight loss by reducing discouragement after weight regain.
How similar studies have gone: Earlier approaches using timely behavioral prompts have shown promise in supporting weight management, but this specific JITAI approach for weight regain is relatively new.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages 18-75 years * BMI of 25-50 kg/m2 * Current weight is 3% lower than their highest weight in the past 3 years * Desire to maintain their weight or lose more * Ability to engage in PA, as defined as being able to walk two full city blocks without stopping * Smartphone and Internet access * Successful completion of all enrollment procedures * Ability to attend a workshop(s) on a Monday or Tuesday evening Exclusion Criteria: * History of bariatric surgery * History of being diagnosed with an eating disorder * Currently pregnant, breastfeeding, or planning to become pregnant in the next 24 months * Enrolled in another formal weight loss/weight maintenance program * Currently taking a GLP-1 medication.
Where it's running
-
Oregon Research Institute Community and Evaluation Services
Springfield, Oregon, United States Recruiting
Study contacts
- Study coordinator: Charlotte Hagerman, PhD
- Email: chagerman@ori.org
- Phone: 14109372035
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
GZC8072 tablets: safety and how the body handles it after a single dose in healthy people and after multiple doses in people who are overweight or obese
This study tests GZC8072 tablets to see if they are safe and how they behave in the body after a single dose in healthy adults and after repeated doses in adults who are overweight or obese.
-
Olatorepatide in adults who are overweight or have obesity (without diabetes) test of safety and dosing
This study tests olatorepatide versus placebo to see if it can safely help adults who are overweight or obese lose weight at different doses.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
Safety and drug levels of REGN20934 in adults with overweight or obesity
This study tests REGN20934 to see if it is safe and how it behaves in the body in adults who are overweight or have obesity.
-
SYH2082 Injection: early-dose safety in adults with overweight or obesity
This early-phase study tests whether a single dose and multiple doses of SYH2082 are safe and well tolerated in healthy adults who are overweight or have obesity.
-
Metformin for older overweight adults with mild cognitive impairment
This will test whether taking metformin alongside lifestyle changes can help thinking and memory in older overweight adults with mild cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.